Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Budget slips happen, but you can regain stability with a simple plan. Identify leaks, prioritize essentials, and set a realistic spending cap to regain confidence.
24,983 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Many retirees fixate on social security everyone fears, but the real danger lies in a mix of health costs, market swi...
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
The weekend U.S.–Iran strike left traditional markets offline, putting on-chain platforms at the center of price disc...
Bitcoin slides below 70,000 as ICP and PI buck the broader market, delivering notable gains while Ethereum fights to ...
Today’s session showed a rally fade for Plug Power and a broader pullback in hydrogen names. This article breaks down...
AMD pulled back after a strong rally as investors weigh the impact of the CIQ Linux partnership on AI and data center...
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
In this stock market today update, Intel pulls back as AI bubble risk concerns rise, even as AI-driven momentum suppo...
March data from the Case-Shiller indices confirms a slower pace of home price growth, signaling ongoing cooling acros...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...